Viatris (VTRS) Long-Term Deferred Tax (2019 - 2026)
Viatris (VTRS) recorded quarterly Long-Term Deferred Tax of $1.1 billion in Q1 2026, up 4.52% quarter-over-quarter from $1.1 billion in Q4 2025, and up 35.67% on a YoY basis from $817.6 million in Q1 2025.
Viatris (VTRS) Long-Term Deferred Tax (2019 - 2026) Analysis & Trends
Viatris' Long-Term Deferred Tax history runs 8 years deep, the most recent figure standing at $1.1 billion for Q1 2026.
- In Q1 2026, Long-Term Deferred Tax rose 35.67% year-over-year to $1.1 billion; the TTM figure through Mar 2026 stood at $1.1 billion (up 35.67% YoY), while the FY2025 annual figure was $1.1 billion, up 40.93% from the prior year.
- Long-Term Deferred Tax was $1.1 billion for Q1 2026 at Viatris, up from $1.1 billion in the prior quarter.
- In the past five years, Long-Term Deferred Tax ranged from a high of $1.3 billion in Q1 2022 to a low of $653.2 million in Q1 2024.
- Historically, Long-Term Deferred Tax has averaged $933.7 million across 5 years, with a median of $930.4 million in 2023.
- The sharpest annual moves came in 2022 and 2025: Long-Term Deferred Tax slumped 43.07% in 2022, then soared 40.93% in 2025.
- A 5-year view of Long-Term Deferred Tax shows it stood at $925.9 million in 2022, then retreated by 25.16% to $692.9 million in 2023, then gained by 8.67% to $753.0 million in 2024, then jumped by 40.93% to $1.1 billion in 2025, then gained by 4.52% to $1.1 billion in 2026.
- The last three Long-Term Deferred Tax figures came in at $1.1 billion (Q1 2026), $1.1 billion (Q4 2025), and $999.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Viatris | - | - | 1.16 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.11 Bn |
| Dec 31, 2025 | 1.06 Bn |
| Sep 30, 2025 | 999.00 Mn |
| Jun 30, 2025 | 924.30 Mn |
| Mar 31, 2025 | 817.60 Mn |
| Dec 31, 2024 | 753.00 Mn |
| Sep 30, 2024 | 763.10 Mn |
| Jun 30, 2024 | 685.30 Mn |
| Mar 31, 2024 | 653.20 Mn |
| Dec 31, 2023 | 692.90 Mn |
| Sep 30, 2023 | 930.40 Mn |
| Jun 30, 2023 | 966.00 Mn |
| Mar 31, 2023 | 959.10 Mn |
| Dec 31, 2022 | 925.90 Mn |
| Sep 30, 2022 | 1.10 Bn |
| Jun 30, 2022 | 1.24 Bn |
| Mar 31, 2022 | 1.29 Bn |
| Dec 31, 2021 | 1.33 Bn |
| Sep 30, 2021 | 1.45 Bn |
| Jun 30, 2021 | 2.18 Bn |